RecruitingNCT07508007

Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings

Studying Isolated pulmonary artery sling

Last synced from ClinicalTrials.gov May 12, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Novartis Pharmaceuticals
Principal Investigator: Novartis Pharmaceuticals
Novartis Pharmaceuticals
Enrollment: 4500 enrolled
Eligibility: 18 years · All sexes
Timeline: 2025 – 2028

Study locations (1)

Novartis Investigative Site, Nuremberg, Germany

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07508007 on ClinicalTrials.gov

Other trials for Isolated pulmonary artery sling

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT07517263
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Novartis Pharmaceuticals
RECRUITINGPHASE1NCT07513571
A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults
AstraZeneca
ACTIVE NOT RECRUITINGNCT07533656
VAP-Measured Lipid Subfractions and In-Stent Restenosis After PCI
Second Affiliated Hospital, School of Medicine, Zhejiang University

See all trials for Isolated pulmonary artery sling →

← Back to all trials